Clinical trials of adrenergic antagonists in pregnancy hypertension.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001034:Apgar Score; D001724:Birth Weight; D005260:Female; D005317:Fetal Growth Retardation / Q000453:epidemiology; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007231:Infant, Newborn; D008750:Methyldopa / Q000627:therapeutic use; D008790:Metoprolol / Q000627:therapeutic use; D010096:Oxprenolol / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D012127:Respiratory Distress Syndrome, Newborn / Q000453:epidemiology
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D006830:Hydralazine; D010096:Oxprenolol; D008750:Methyldopa; D008790:Metoprolol